Pascal Deschatelets, Chief Scientific Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 4,576 shares at $28.70 ($131K) on 2025-01-13, disclosed to the SEC on 2025-01-14.
Seasonal sale ($131k) by Chief Scientific Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.70 | 2,288 | $66K | 50.0% |
| 2 | $28.70 | 2,288 | $66K | 50.0% |
| Total | $28.70 avg | 4,576 | $131K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $51K | — | Filing → |
| APLS | SELL | 2025-01-30 | $24K | — | Filing → |
| APLS | SELL | 2025-01-23 | $240K | — | Filing → |